Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic compli...
Enregistré dans:
Auteurs principaux: | Dimitrios Alexopoulos, Charalampos Varlamos, Despoina-Rafailia Benetou |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7cd2d99bafad4623b7befa5181ab0d7c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
par: Despoina-Rafailia Benetou, et autres
Publié: (2021) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
par: Despoina-Rafailia Benetou, et autres
Publié: (2021) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
par: Charalampos Varlamos, et autres
Publié: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
par: Iosif Xenogiannis, et autres
Publié: (2021) -
Role of Intravascular Ultrasound in Guiding Complex Percutaneous Coronary Interventions
par: Brandon Quintana, et autres
Publié: (2020)